PET/CT restaging alters breast cancer management

August 1, 2008 Diagnostic Imaging. PET/CT restaging alters breast cancer management -------------------------------------------------------------------------------- FDG-PET/CT's power for staging and restaging breast cancer is attracting attention. It could also detect recurrence in more than two-thirds of these patients and change the management plan in up to a third, according to German investigators. Dr. Michael Souvatzoglou and colleagues in the nuclear medicine department at the Technical University of Munich prospectively enrolled 118 patients with suspicion of breast cancer recurrence based on elevated tumor markers, clinical signs, and abnormal standard imaging studies. PET/CT identified local and metastatic disease in 79 cases.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC